Continuous glucose monitoring improves quality of life in T1DM

(HealthDay)—Continuous glucose monitoring (CGM) contributes to significant improvements in diabetes-specific quality of life (QOL) measures among adults with type 1 diabetes mellitus (T1DM), according to a study published online April 7 in Diabetes Care.

William H. Polonsky, Ph.D., from University of California, San Diego, and colleagues evaluated quality of life data for 158 patients participating in the DIAMOND randomized trial assessing CGM versus self-monitoring of (SMBG) in adults with poorly-controlled T1DM.

The researchers found that the CGM group showed a greater increase in hypoglycemic confidence (P = 0.01) and a greater decrease in diabetes distress (P = 0.01), compared to the SMBG group. There were no significant differences in well-being, health status, or hypoglycemic fear between the groups. CGM satisfaction was not significantly associated with glycemic changes.

"CGM satisfaction was associated with most of the QOL outcomes but not with glycemic outcomes," the authors write.

Two authors disclosed financial ties to the medical device industry, including Dexcom, which funded the study.


Explore further

Metreleptin doesn't improve glycemic control in T1DM

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Copyright © 2017 HealthDay. All rights reserved.

Citation: Continuous glucose monitoring improves quality of life in T1DM (2017, April 14) retrieved 20 September 2019 from https://medicalxpress.com/news/2017-04-glucose-quality-life-t1dm.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more